US Earnings Financial Results SEC Filings — June 18, 2026

18-06-2026

Salamander Innisbrook, LLC filed its 10-K annual report for the year ended December 31, 2025, reporting a net loss of $2,145,633, which widened by 6.8% from a net loss of $2,008,926 in 2024. Total revenues declined 1.6% to $46,492,085, driven by a 10.6% drop in room revenues to $8,607,124, while other revenues grew modestly by 0.8% to $37,884,961. Operating loss increased 57.6% to $2,575,139, though cash provided by operations improved significantly to $1,953,174 from $79,708 in the prior year.

• · Total assets decreased to $53,601,004 as of December 31, 2025 from $55,803,341 a year earlier.
• · Total liabilities remained relatively flat at $22,903,777 in 2025 versus $22,960,481 in 2024.
• · Property, buildings and equipment, net declined to $33,813,375 from $34,518,751.
• · Accounts receivable (net) decreased to $2,326,930 from $2,718,640.
• · Deferred revenues (current portion) increased to $5,613,914 from $4,825,840.
• · Due to affiliates increased to $2,358,563 from $1,148,789.
• · Note payable (net of current portion) decreased to $6,598,871 from $7,469,831.
• · Cash paid for interest decreased to $501,861 from $604,933.
• · Quarterly cash balances declined sequentially from $9,301,183 (March 31, 2025) to $7,595,794 (September 30, 2025).
• · Gain from insurance recovery of $744,555 and gain on sale of assets of $65,223 were recognized in 2025, with no comparable items in 2024.

18-06-2026

Earth Science Tech, Inc. (ETST) reported revenue growth of 8% YoY to $35.7M for FY2026, with net income increasing 11% to $3.6M. However, operating cash flow declined sharply by 56% to $1.94M, and the company ended the year with cash of $0.8M, down 46% from $1.47M. Total assets grew 27% to $8.97M, while total liabilities decreased 40% to $1.93M, resulting in a significantly improved equity position.

• · Advertising & marketing expenses surged 239% YoY to $2.84M, driving revenue growth but pressuring margins.
• · Depreciation and amortization increased 427% YoY to $284,396, reflecting higher capital investment.
• · Unrealized loss on investments widened to $957,118 from $365,661, a 162% increase.
• · The company eliminated all short-term business loans ($179,488) and long-term debt ($31,427) during FY2026.
• · A deferred tax asset of $772,294 was recognized in FY2026, contributing to a tax benefit of $511,676 vs. an expense of $116,776 in FY2025.
• · Goodwill increased 15% to $2.65M, and intangible assets more than doubled to $208,170, indicating acquisition activity.
• · The company repurchased and retired 4,023,296 common shares during FY2026, reducing outstanding shares and boosting EPS.
• · Non-controlling interest of $30,287 was recorded for the first time, reflecting a subsidiary acquisition.
• · Net cash used in financing activities improved to $712,917 from $1.72M, primarily due to lower debt repayments and share repurchases.

18-06-2026

International Battery Metals Ltd. reported a net income of $122,000 for the fiscal year ended March 31, 2026, a significant improvement from a net loss of $3.516 million in the prior year, driven primarily by a $16.493 million gain from the change in fair value of warrant liability. However, total revenue declined sharply by 81% to $164,000 from $871,000, and operating loss improved only modestly to $13.493 million from $15.203 million. Cash used in operations decreased to $9.667 million from $13.455 million, but the company ended the period with $9.187 million in cash, down from $10.737 million, as financing activities provided only $8.518 million compared to $24.494 million in the prior year.

• · Revenue shifted from $871,000 in reimbursable revenue in FY2025 to $164,000 in service revenue in FY2026, with no reimbursable revenue in the current year.
• · Gross margin fell to $130,000 from $871,000, a decline of 85.1%.
• · Operating costs excluding depreciation decreased 41.2% to $2.078 million from $3.533 million.
• · Selling, general and administrative expenses decreased 6.4% to $8.460 million from $9.042 million.
• · Depreciation increased 29.4% to $2.009 million from $1.552 million.
• · The company recorded a $2.442 million loss on warrants modification in FY2026, with no such item in FY2025.
• · Bad debt expense was zero in FY2026 versus a $502,000 expense in FY2025.
• · Other income was $3,000 in FY2026 versus zero in FY2025.
• · Cash used in investing activities decreased 69.8% to $401,000 from $1.328 million.
• · Equipment purchases included in trade payables were zero in FY2026 versus $119,000 in FY2025.
• · Shares issued for debt settlement totaled $679,000 in FY2026, with no such issuance in FY2025.
• · Accounts receivable settled through share cancellation was $75,000 in FY2026, with no such item in FY2025.
• · Private placement proceeds allocated to warrant liability decreased 63.3% to $8.428 million from $22.972 million.
• · Share issuance costs decreased 20.0% to $482,000 from $602,000.
• · Subscription received for private placement was zero in FY2026 versus $679,000 in FY2025.
• · Accounts payable decreased 69.5% to $395,000 from $1.293 million.
• · Accrued liabilities increased 67.4% to $892,000 from $533,000.
• · Obligation to issue shares, related party was zero as of March 31, 2026 versus $679,000 as of March 31, 2025.
• · Lease obligation (current) increased 11.2% to $99,000 from $89,000.
• · Lease obligation (long-term) decreased 69.2% to $44,000 from $143,000.
• · Right of use asset decreased 39.2% to $141,000 from $232,000.
• · Intangible assets, net decreased 32.9% to $2.190 million from $3.266 million.
• · Plant and equipment, net decreased 5.7% to $26.842 million from $28.450 million.
• · Inventory remained flat at $1.061 million.
• · Accounts receivable, net decreased 80.4% to $90,000 from $459,000.
• · Other current assets decreased 8.1% to $251,000 from $273,000.
• · Total current assets decreased 15.5% to $10.589 million from $12.530 million.
• · Total current liabilities decreased 46.6% to $1.386 million from $2.594 million.
• · Accumulated deficit improved slightly to $39.444 million from $39.566 million.
• · Net income per share (basic and diluted) was $0.00 in FY2026 versus a loss of $0.01 in FY2025.
• · Performance-based RSUs for Joseph Mills and Michael Rutledge are tied to milestones: building two additional MDLE plants, listing on a major stock exchange, EBITDA targets ($25M and $50M), market capitalization targets ($750M and $1.5B), and a production award based on 0.5% fully diluted shares.
• · Joseph Mills holds a total of 6,804,525 RSUs with a grant date fair value of $1,247,605.
• · Michael Rutledge holds a total of 2,912,036 RSUs with a grant date fair value of $713,531.
• · Time-based RSUs: 1,000,000 for Mills and 450,000 for Rutledge vesting on first anniversary of employment.
• · PSUs for listing on Toronto Stock Exchange: 500,000 for Mills and 300,000 for Rutledge.
• · PSUs for EBITDA: 2,152,262 for Mills and 968,518 for Rutledge at $25M target; 2,152,263 for Mills and 968,518 for Rutledge at $50M target.
• · PSUs for market capitalization: 0.5% fully diluted shares for Mills and 0.25% for Rutledge at $750M target; additional 0.5% for Mills and 0.25% for Rutledge at $1.5B target.
• · Production Award to be granted on Feb 7, 2027: 0.5% fully diluted shares for both Mills and Rutledge.
• · The independent registered public accounting firm has PCAOB ID 199.

18-06-2026

Starlink AI Acquisition Corp (OTAI) reported a net loss of $32,856 for the three months ended April 30, 2026, with total assets of $718,184 and total shareholders' deficit of ($62,643). The company had cash of $399,100 at period end, up from $100,000 at January 31, 2026, but remains in a deficit position with accumulated deficit growing to ($87,643) from ($54,787).

• · Formation and operating costs for the three months ended April 30, 2026 were $32,856.
• · Net cash used in operating activities was $35,856, while net cash provided by financing activities was $334,956.
• · The company had no revenue and no accrued expenses at April 30, 2026 (down from $3,000 at January 31, 2026).
• · Basic and diluted net loss per share was ($0.01) for the period.
• · Ordinary shares authorized: 500,000,000; issued and outstanding: 2,875,000.

18-06-2026

Accenture plc reported Q3 FY2026 (period ended May 31, 2026) revenues of $18.718B, up 5.6% YoY from $17.728B, and net income attributable to Accenture of $2.339B, up 6.4% YoY. For the nine-month period, revenues grew 6.6% to $55.504B and net income attributable to Accenture increased 1.8% to $6.376B. However, operating cash flow improved significantly to $9.268B from $7.560B, while cash and cash equivalents declined to $10.165B from $11.479B at fiscal year-end, and the company repurchased $5.19B in shares during the nine months.

• · Total assets increased to $68.807B from $65.395B at fiscal year-end, driven by a $2.786B increase in goodwill to $25.323B.
• · Total shareholders' equity rose to $33.014B from $32.241B, with retained earnings increasing to $24.026B from $21.019B.
• · Business optimization costs of $307.5M were recorded in the 9-month period (none in prior year).
• · Operating income for Q3 was $3.175B (up 6.5% YoY) and for 9 months was $8.543B (up 4.5% YoY).
• · Cash used in investing activities was $3.452B, up from $1.248B, primarily due to $3.004B in business acquisitions.
• · Net cash used in financing activities was $7.091B, up from $1.673B, driven by higher share repurchases and dividends.
• · The company's effective tax rate for the 9-month period was 24.3% (income tax expense of $2.085B on pre-tax income of $8.574B).
• · Foreign currency translation resulted in a $12.7M loss for the 9-month period (vs. $96.6M gain in prior year).
• · Redeemable noncontrolling interests of $493.9M were recorded as of May 31, 2026 (none at August 31, 2025).

18-06-2026

Grace Therapeutics, Inc. (GRCE) filed its 10-K for the fiscal year ended March 31, 2026, reporting a net loss of $7.8 million, an improvement from the $9.6 million net loss in the prior year. Revenues remain absent; the net loss narrowed primarily due to a significant 75% reduction in R&D expenses to $2.4 million, offset by a 21% increase in G&A expenses to $8.7 million.

• · Third-party R&D expenses dropped 89% from $8.5M to $0.9M, driving the overall R&D reduction.
• · Salaries and benefits in R&D increased 54% to $1.2M, partially offsetting the decline in third-party spend.
• · Professional fees drove the G&A increase, up 23% to $4.3M.
• · Derivative warrant liabilities were fully extinguished in FY2026 (zero balance vs. $1.1M prior year).
• · Deferred tax liability fell 74% from $2.3M to $612K, contributing to a $1.7M income tax benefit.
• · Company raised $4.3M from exercise of common warrants during FY2026.
• · Accumulated deficit reached $228.5M, a $7.8M increase during the year.
• · Stock-based compensation totaled $798K in FY2026 (vs. $730K in FY2025).

18-06-2026

Basin Electric Power Cooperative reported net margin attributable to Basin Electric of $75.4M for Q1 2026, up 58% from $47.7M in Q1 2025. Total operating revenues increased 8% to $841.2M, driven by higher member sales and other revenues. However, total other comprehensive loss widened to $(6.4M) from $(1.5M), primarily due to unrealized losses on cash flow hedges.

• · Total assets increased to $9.48B as of March 31, 2026 from $9.40B at December 31, 2025.
• · Patronage capital rose to $1.58B from $1.52B.
• · Total equity increased to $2.05B from $1.98B.
• · Long-term debt decreased slightly to $4.94B from $4.95B.
• · Operating margin improved to $102.6M from $76.2M.
• · Other comprehensive loss was $(6.4M) compared to $(1.5M) in the prior year quarter.
• · Income tax expense decreased to $1.1M from $4.8M.

18-06-2026

Medtronic's fiscal 2026 annual report shows GAAP net income of $4,801M ($3.73 diluted EPS) on revenue of $36,364M, an 8% increase over prior year. Non-GAAP net income rose 1% to $7,120M ($5.53 diluted EPS). However, the GAAP effective tax rate increased sharply to 21.2% from 16.6% a year ago, and free cash flow grew only 5% to $5,426M, lagging revenue growth.

• · Net cash from operations increased to $7,330M from $7,044M.
• · Capital expenditures (PP&E additions) were $1,904M in FY2026 vs $1,859M in FY2025.
• · Net cash used in investing activities was $2,934M in FY2026, up from $1,937M in FY2025.
• · Net cash used in financing activities was $4,751M in FY2026, up from $4,361M in FY2025.
• · Net change in cash and cash equivalents was negative $269M in FY2026 after a positive $934M in FY2025.
• · Amortization of intangible assets decreased slightly to $1,772M from $1,807M.
• · Restructuring charges, net decreased to $249M from $267M.
• · Certain litigation charges, net dropped sharply to $113M from $317M.
• · Other operating expense (income), net swung to $386M expense from $(23)M income.
• · Interest expense, net was $715M in FY2026 vs $729M in FY2025.
• · GAAP income tax provision rose to $1,299M from $936M year-over-year.
• · Non-GAAP income tax provision increased to $1,499M from $1,423M.
• · U.S. net sales grew 5% to $18,103M; International net sales grew 12% to $18,261M.
• · Diabetes International net sales surged 19% to $2,178M, while Diabetes U.S. net sales grew only 1% to $934M.
• · Other operating segment International net sales declined 23% to $54M.

18-06-2026

Central Plains Bancshares, Inc. (CPBI) reported net income of $4.0M for the fiscal year ended March 31, 2026, an increase of 9.5% from $3.654M in the prior year. While net interest income grew 13.2% to $18.674M, non-interest expense rose 11.6% to $16.044M, and non-performing assets increased 36.2% to $1.949M, with total non-accrual loans rising to $1.641M from $1.329M. Total assets grew 9.8% to $558.647M, and deposits increased 10.6% to $460.356M.

• · Interest income increased to $27.665M from $24.703M, up 12.0%.
• · Interest expense increased to $8.991M from $8.214M, up 9.5%.
• · Non-interest income grew modestly to $2.667M from $2.610M, up 2.2%.
• · Income before tax increased to $4.991M from $4.523M, up 10.3%.
• · Net interest rate spread improved to 3.07% from 2.76%.
• · Net interest margin rose to 3.80% from 3.56%.
• · Total non-accrual loans increased to $1.641M from $1.329M, up 23.5%.
• · Agricultural non-accrual loans were $1.632M at March 31, 2026, up from $0 in the prior year.
• · Accruing loans past due 90 days or more increased to $234K from $102K, up 129.4%.
• · Cash and cash equivalents were $29.929M, up from $28.682M.
• · Investment securities held-to-maturity decreased to $175K from $222K.
• · Investment securities available-for-sale increased to $62.534M from $59.369M.
• · Loans, net of allowance for credit losses, increased to $442.537M from $396.756M.
• · Total liabilities increased to $469.657M from $425.370M.
• · Total equity increased to $88.990M from $83.332M.
• · Interest rate sensitivity analysis shows net interest income would increase by 1.43% under a +400 basis point scenario and decrease by 1.45% under a -400 basis point scenario.
• · Weighted average exercise price of outstanding options is $14.63.
• · The report of Independent Registered Public Accounting Firm is on page 51.

18-06-2026

Piermont Valley Acquisition Corp (CMCAW) filed its 10-K for the fiscal year ended March 31, 2026, reporting a net loss of $1,696,790 compared to net income of $1,637,099 in the prior year. The company's cash held in trust increased to $2,456,980 from $2,382,346, but total liabilities decreased to $1,480,009 from $2,041,274. The company continues to face a going concern risk and has not yet completed a business combination.

• · The company's registered independent public accountants included an explanatory paragraph regarding the company's ability to continue as a going concern.
• · The company has not yet completed a business combination and faces risks related to selecting a target, obtaining financing, and potential liquidation.
• · Basic and diluted net loss per share for all classes was $(0.28) for the year ended March 31, 2026, compared to income of $0.24 per share in the prior year.
• · Warrant liability - public warrants increased dramatically from $16,307 to $1,150,000, while private warrants were reduced to zero.
• · Advances from related party increased from $64,056 to $255,797, while note payable - sponsor was fully repaid (reduced from $1,471,195 to $0).
• · Interest income on trust account dropped 85% from $541,412 to $81,077, likely due to lower interest rates or reduced trust balance.

18-06-2026

Shreya Acquisition Group reported a net loss of $97,808 for the nine months ended March 31, 2026, compared to a net loss of $6,665 at June 30, 2025, reflecting a significant increase in losses. The company had no revenue and total assets of $156,405, while total liabilities exceeded shareholder equity, resulting in a shareholder deficit of $79,473. The company's cash balance remained at $0 throughout the period.

• · The company had no revenue and no cash at the end of the period.
• · Deferred offering costs increased from $50,000 at June 30, 2025 to $153,517 at March 31, 2026.
• · Accrued expenses of $46,407 and accrued offering costs of $46,226 were recorded as of March 31, 2026, compared to $0 for both at June 30, 2025.
• · Due to related party increased from $32,815 at June 30, 2025 to $143,245 at March 31, 2026.
• · Net cash used in operating activities was $0 for the nine months ended March 31, 2026.
• · On May 8, 2026, the underwriters partially exercised the over-allotment option, reducing the number of Class B ordinary shares subject to forfeiture from 642,857 to 214,286.
• · The company had no Class A ordinary shares issued or outstanding as of March 31, 2026.

18-06-2026

Jerash Holdings (US), Inc. reported a strong turnaround in fiscal 2026, with revenue increasing 14% YoY to $166.3M and net income of $3.6M compared to a net loss of $0.8M in fiscal 2025. However, sales to its largest customer, VF Corporation, declined 7.6% to $87.0M, reducing its share from 64.6% to 52.3% of total revenue. Cash and restricted cash decreased by $2.6M to $12.5M, and cash flow from operations was only $2.5M, constrained by increases in accounts receivable and inventory.

• · Cost of goods sold increased 13% YoY to $139.5M, but as a percentage of revenue improved from 85% to 84%.
• · Selling, general, and administrative expenses decreased 2% YoY to $20.5M, dropping from 14% to 12% of revenue.
• · Other expenses, net increased 22% YoY to $1.6M.
• · Income tax expense increased 13% YoY to $1.1M.
• · Net cash used in investing activities was $5.8M in fiscal 2026, up from $2.4M in fiscal 2025.
• · Net cash provided by financing activities was $0.7M in fiscal 2026, down from $2.1M in fiscal 2025.
• · Accounts receivable increased by $2.7M in fiscal 2026, compared to a decrease of $2.4M in fiscal 2025.
• · Inventory increased by $2.3M in fiscal 2026, compared to an increase of $0.5M in fiscal 2025.
• · Deferred revenue decreased by $0.2M in fiscal 2026, compared to an increase of $0.5M in fiscal 2025.
• · Revenue from Jordan declined 29% YoY to $2.2M, and revenue from other regions declined 60% YoY to $2.1M.

18-06-2026

American Honda Finance Corp. filed its 10-K annual report for the fiscal year ended March 31, 2026, reporting total consolidated revenues of $10,607 million, up 12% from $9,489 million in the prior year. However, consolidated income before income taxes and valuation adjustments declined 21% to $1,292 million from $1,645 million, driven by a 27% drop in the U.S. segment, while the Canada segment showed a 13% increase.

• · Total consolidated net revenues (total net revenues) decreased 2% to $2,639 million from $2,684 million, with the US segment declining 4% to $2,290 million while Canada grew 16% to $349 million.
• · Provision for credit losses increased 20% in the US to $351 million and 100% in Canada to $26 million, indicating higher expected credit losses.
• · Early termination loss on operating leases surged 118% in the US to $294 million and 400% in Canada to $5 million (from $1 million), reflecting significant lease termination activity.
• · Total assets grew 2.5% to $91,206 million, while total debt increased 3.6% to $64,788 million, with the debt-to-asset ratio remaining stable.
• · Shareholder's equity decreased slightly by 0.2% to $16,565 million, while retained earnings declined to $15,369 million from $15,448 million.
• · Total termination units (consolidated) decreased 23% to 340,000 units from 444,000 units in the prior year, with US termination units down 26% to 279,000 units.
• · The effective yield on US retail loans improved to 6.2% from 5.9%, while Canada retail loans yield improved to 6.3% from 6.0%.
• · The effective interest rate on total debt decreased to 4.3% from 4.4% in the US and to 3.5% from 4.2% in Canada, reflecting lower borrowing costs.
• · Commercial paper outstanding decreased significantly to $2,929 million from $6,022 million, while the Public MTN Program increased to $40,726 million from $37,153 million.
• · Related party debt was $0 as of March 31, 2026, down from $1,800 million in the prior year.